MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/igc.0000000000000810

Медицинская библиотека · International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2016

Radiation Therapy for Recurrent Clear-Cell Cancer of the Ovary.

Westhoff Gina L, Fuh Katherine C, Longacre Terry A, McNally Jennifer Leah, Hsu I-Chow, Kapp Daniel S, Teng Nelson, Chen Lee-May

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Given the relative chemo-resistant nature of clear-cell gynecologic cancers, we investigated the utility of radiation therapy (RT) to treat recurrent clear-cell carcinoma (CCC) of the ovary.

METHODS

A retrospective chart review of patients with recurrent CCC managed from 1994-2012 was conducted at 2 academic medical centers. Demographic and clinicopathologic factors were abstracted and evaluated using Pearson χ or t tests, Kaplan-Meier and Cox regression analyses.

RESULTS

Fifty-three patients had recurrent CCC, and 24 (45.3%) of these patients received RT. There were no significant differences in age, stage, optimal cytoreduction, platinum response, or the percentage of patients that received more than 3 regimens of chemotherapy between the 2 groups. Patients who received RT for recurrent CCC were more likely to have had a focal recurrence (62.5% vs 10.3%, P ≤ 0.001) and to have undergone secondary cytoreduction (70.8% vs 10.3%, P ≤ 0.001). Of patients who received RT, 73.9% underwent surgery with or before their treatment. Five-year survival after recurrence was significantly higher in the group that received RT, 62.9% versus 18.8% (P = 0.002). In a multivariate analysis, platinum-sensitive disease and RT were associated with improved survival from recurrence, (hazard ratio, 0.26; 95% confidence interval, 0.08-0.81; P = 0.02 and hazard ratio, 0.28; 95% confidence interval, 0.09-0.90, P = 0.03, respectively).

CONCLUSIONS

In this cohort of patients with recurrent CCC, platinum-sensitive disease and RT are associated with improved survival. However, it is important to note that the majority of these patients underwent surgery along with RT, and it may be that the benefit of RT is limited to those who undergo secondary cytoreduction.

Для цитирования: Westhoff Gina L, Fuh Katherine C, Longacre Terry A, McNally Jennifer Leah, Hsu I-Chow, Kapp Daniel S, Teng Nelson, Chen Lee-May. Radiation Therapy for Recurrent Clear-Cell Cancer of the Ovary.. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2016. DOI: 10.1097/igc.0000000000000810.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.